Everyday Health

Share

Everyday Health

 •  January 10

Whether it’s a whole new approach or an improvement on an old drug, every single cancer drug on the market needs to go through a clinical trial. Yet a study presented in September 2017 at the European Society for Medical Oncology (ESMO) in Madrid pointed out that only a small fraction of people with cancer — three to five percent — sign up for...

Everyday Health

 •  November 8, 2017

Treatment is one of the first things doctors talk about with you after you’re diagnosed with ulcerative colitis (UC). Everything from medications that are going to be prescribed, any infusions that you will have to regularly receive, and possible side effects are major topics of conversation with your healthcare team. Since ulcerative colitis does...

Everyday Health

 •  October 6, 2017

A newer drug may beat the standard treatment when it comes to battling the blood cancer follicular lymphoma, a clinical trial suggests. Follicular lymphoma is one type of non-Hodgkin lymphoma, a group of cancers that arise in white blood cells. The new study found that a drug called obinutuzumab (Gazyva) typically kept the cancer under control...

Everyday Health

 •  October 2, 2017

Long-term treatment with the drug rituximab (Rituxan) may extend the lives of some patients with a rare form of blood cancer, a new clinical trial finds. The disease, known as mantle-cell lymphoma, is generally incurable. But various treatments can prolong people's lives. Some patients, for instance, are able to undergo chemotherapy to wipe out the...

Everyday Health

 •  May 19, 2017

Few could be happy with the condition of the political system in America’s capital at the moment. Scandals and counter-scandals, finger-pointing, navel-gazing, and partial truths abound. It would be easy to think that none of the People’s work was actually getting done. I had a little bit of faith restored when I read of a new, bipartisan bill that...